Chengdu Drug and Cancer Pharmaceutical Technology Co.,Ltd.

Chengdu Drug and Cancer Pharmaceutical Technology Co., Ltd, is an innovative enterprise specializing in R&D, manufacturing and sales of APIs and Intermediates, located in Gaoxin District, Chengdu. Our company adhere to the development strategy of "One focus, one platform". Establish a continuous-flow synthesis technology platform for hazardous chemical process development. The company has R&D center in Chengdu, and production base in Mianyang, Sichuan. The company has a lean R & D team mainly composed of doctors and masters, and will further introduce more talents, increase the investment in R & D expenses, and strengthen the first-class anti-tumor drug R & D platform. The company's existing R & D achievements: Alectinib, Pemigatinib, Rimegepant, GLPG-3667; the ton production of 2-nitro-4-fluoroaniline; and the establishment of a production line for 5-aminoisophthalic acid, the key intermediate of contrast agent with an annual output of 550 tons. The company takes "Loyalty, Responsibility, Innovation and Sharing" as its core values, takes "Innovation and Excellence" as its R & D mission, and adheres to the business philosophy of "Hand in hand with customers and create the future together", to be an outstanding pharmaceutical intermediate supplier in the field in the world.